| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | 8.9 | 4.4 | 4.9 |
| Total income | 80.5 | 87.9 | 75.5 |
| Net profit | 6.6 | 7.9 | 0.1 |
| Operating margin | 7.2% | 11.7% | -3.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +6500.00% |
|---|---|
| Net profit, quarter on quarter | -16.50% |
BSE results filing, NSE: QUICKHEAL. Figures extracted from the filing.
Quick Heal Technologies Ltd: key numbers
- Share price
- ₹145.92
- Market cap
- ₹792.0 Cr
- Revenue (annual)
- ₹261.0 Cr
- Net profit (annual)
- ₹-10.93 Cr
- P/E (TTM)
- -74.0×Sector 21.4×
- Promoter holding
- 71.48%-0.02% QoQ
- FII holding
- 0.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Quick Heal Technologies Ltd
All →Quick Heal Technologies Management Change
Quick Heal Technologies Limited shareholders approved the re-appointment of Mr. Richard Stiennon as a Non-Executive Independent Director for a second five-year term, effective September 27, 2026.
Quick Heal Technologies Annual General Meeting
Quick Heal Technologies held its 31st Annual General Meeting on September 23, 2026, to conduct business, including the adoption of financial statements and director appointments.
Quick Heal Technologies Management Change
Quick Heal Technologies' Chief Marketing Officer, Sudhanshu Tripathi, has resigned from the company effective September 16, 2026, to pursue other professional opportunities.
Quick Heal Technologies Price Movement Clarification
Quick Heal Technologies responded to NSE's volume-spurt query, stating all Reg 30 disclosures were made. The company attributes the increase to normal market forces with no undisclosed material event.
Quick Heal Technologies Employee Stock Options
Quick Heal Technologies Limited has allotted 9,746 equity shares following the exercise of options under its ESOP Scheme 2021. The exercise prices ranged from ₹114 to ₹122.
Quick Heal Technologies Management Change
Quick Heal Technologies Ltd has appointed Mr. Amit Chaudhary as Vice President – Product Management. This appointment is effective from September 01, 2026.